var data={"title":"Society guideline links: HIV treatment in nonpregnant adults and adolescents","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Society guideline links: HIV treatment in nonpregnant adults and adolescents</div><p class=\"disclosureLink\"></p><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1187718400\"><span class=\"h1\">Introduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.</p><p>The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.</p><p>Links to related guidelines are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-sexually-transmitted-infections\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Sexually transmitted infections&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-opportunistic-infections-in-hiv-infected-adults-and-adolescents\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Opportunistic infections in HIV-infected adults and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H612570590\"><span class=\"h1\">International</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://apps.who.int/iris/bitstream/10665/246200/1/9789241511124-eng.pdf?ua=1&amp;token=+lQcxYXJ91WrHOqJpHqVq6jcgxFKjnr0SMNBHH7Y3JMDhgY6Vi6SUOmSGYUDD8vDhRjjl/APG+/ZOt4TNLRnMYcR8eC2azwPGbJdHjQboWY=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">World Health Organization (WHO): Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations, update</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1&amp;token=oSFr6GKEj0xpsyNW3eHKWSSWLFJrpjbNULEwvT4tgtHFyJw88iqm8zALmxhLijdI9DqKgrlGADZVVx9R6CfiqNodzAqR2/tBnO8q7ahg9o0=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection &ndash; Recommendations for a public health approach, 2nd edition</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/&amp;token=DaLUCYncB+XP1WpF6ZWnMTeob9NSLuMCmQExCW35upsG3yPOQSuM207uxcczog6QELuAug2OOg0wGIc7NJfscw==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">WHO: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV</a> (2015)</p><p/><p class=\"headingAnchor\" id=\"H382525013\"><span class=\"h1\">Canada</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ammi.ca/Update/39.ENG.pdf&amp;token=+CjrhIBVW0jZK35njTvgcfpkOUv904h2Jq/vG1LDblA4NVJ1wjDi1WsG0GREwsxQ&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Association of Medical Microbiology and Infectious Disease (AMMI) Canada: Position statement on the use of early antiretroviral therapy in HIV-infected persons</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ammi.ca/Content/ChoosingWiselyCanada/MedicalMicrobiologyAndInfectiousDisease.pdf&amp;token=cLeqPAqBMXEEa0LI/4LHcA47o/WoFP4u03n53H9RpKBYCzRJDaK+XZmRFHR5Bq2PRsZfavtaCalkmW6jJLITS7Md2oRRC21s4tj3vMN6Q8qCNCO7Xvtx8eZugJvSI8/s&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Choosing Wisely Canada: Don't routinely repeat CD4 measurements in patients with HIV infection with HIV-1 RNA suppression for &gt;2 years and CD4 counts &gt;500/mcL, unless virologic failure occurs or intercurrent opportunistic infection develops</a> (2015)</p><p/><p class=\"headingAnchor\" id=\"H3064355763\"><span class=\"h1\">United States</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/hivma-avoid-quarterly-viral-load-testing-with-durable-viral-supression/&amp;token=MppMMDPUuUMLA1NqUVqYXH0SLIR3M0KQD7XkR26qeN2S8iL6TIpr3N+vkqwAGchDRB2dpN8LEx+QGWGYub4oZ8xTzKNUL09KEttTXdg8mLodz6lyBfQ9iv0akz6+aJDmK65UmZJibdxoXu9GtSzxhw==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Choosing Wisely: Avoid quarterly viral load testing of patients who have durable viral suppression, unless clinically indicated</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/hivma-avoid-unnecessary-cd4-tests/&amp;token=a21HGz0oTZRdbg7tpilqPwwh6DtRrPETqKq+dq7csIq0Wu9+k2HaEWjen8f/DaQg0GAcjB8OBV4AjIPENjTTc57FuVHVkHflr3Ne9dTn3aw=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Choosing Wisely: Avoid unnecessary CD4 tests</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/hivma-avoid-ordering-lymphocyte-panels-with-cd4-counts/&amp;token=/oO0sUiiaR2AVQANqEmgUm8+JThCWRgYbtPZ3T0pPpWG+vLi+YIg1tpGWFmk0CZRIu46CFcIcqQifo5ChJ2ZAna1OpjYX2zpnnQrFFtM6koSJLcINjZjjIASRinMCNI7&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Choosing Wisely: Don't order complex lymphocyte panels when ordering CD4 counts</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf&amp;token=RhwH1LNIzPw9WOY2pDBGGxsevrv7Xpu0ZPAPR/zMD3x32EiqCyPz+DgHzu7Go0mPoS4qxxUT7n21cI8DkrQ/9vV8FwRiCzeCCSxnMOqJ2t4=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Department of Health and Human Services (DHHS): Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://jamanetwork.com/journals/jama/fullarticle/2533073&amp;token=TEHXC8R7Cdwgpocpwm3NzhWJ/+zlCrhxRHYPh9M4cx8RdVkYFqMZVjMCmzw0nULJ1RLiVLuEa1SgO7j6eWDubg==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">International Antiviral Society&ndash;USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV infection in adults</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.cdc.gov/std/tg2015/tg-2015-print.pdf&amp;token=R4Uiw8/bmPVaqNHRDqpXLKy1Ja7NNbTQNlMM7q+2yK4OkwmJc+s7K0PH4P9UDl3HZ+Qu/jb/hF0pSViGf8s78A==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention (CDC): Sexually transmitted diseases treatment guidelines</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/cid/article-lookup/58/1/e1&amp;token=i+IJbZ3566jvLjqylaYc8D23O/k2m8qRPrU4n4GJeOlCd9XderSkx9EoVSnSbVxy2qkUS95Vo9Y7GBj3ij0uzw==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Infectious Diseases Society of America (IDSA): Primary care guidelines for the management of persons infected with HIV, 2013 update</a> (published 2014)</p><p/><p class=\"headingAnchor\" id=\"H1634977207\"><span class=\"h1\">Europe</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html&amp;token=/ojvMRnG8olqqAXgAP7GAozLYDodMUledPwl0KbXkYz5onpdAJaKGPOXAkhIS82pab5BfPU0BCzR2qukfjhmtQ==&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">European AIDS Clinical Society (EACS): Guidelines</a> (2017)</p><p/><p class=\"headingAnchor\" id=\"H748854177\"><span class=\"h1\">United Kingdom</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.bhiva.org/documents/Guidelines/Monitoring/2016-BHIVA-Monitoring-Guidelines.pdf&amp;token=srDXoyReDkWvsLxKXzl0NIOH1iEv31obf9mcFGNmxIH4WH0YH2hy3OCdwGMzMwKX0bZyO43sKZgEc06Ate3h9wRB00K5GWdB9dzO0lvWVTRZXIREMSOQAOcj08EbRawr&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">British HIV Association (BHIVA): Guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.bhiva.org/documents/Guidelines/Treatment/2016/treatment-guidelines-2016-interim-update.pdf&amp;token=+9cuxb8Co4Df4LR8g0x/pRPO4sBT3dnhyvvgi5X0XqBIXbVGpKU/00HqIOKxJNU06xsVVTK7lfj18DCzWdrEoqUgygEq28/eZewM9O5VScdxRtCeLWB21IUOiR8NDrLh&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">BHIVA: Guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy</a> (2015, updated 2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.bhiva.org/documents/Guidelines/TB/hiv_954_online_final.pdf&amp;token=srDXoyReDkWvsLxKXzl0NIOH1iEv31obf9mcFGNmxIHB9OPZhngneTdt0w/D1A9QG95HPnCxGk+Oes+IQyaf21H8L7zdtTic/JrQgLrMuxE=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">BHIVA: Guidelines for the treatment of TB/HIV coinfection</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.bhiva.org/documents/Guidelines/HIV-2/hiv_889.pdf&amp;token=srDXoyReDkWvsLxKXzl0NIOH1iEv31obf9mcFGNmxIHwZjJXR4XtYP9dIr9ZlE2eZrC0iUUWfg270CLoVOMCNbZEbabfDPNDPv79n8P4ta4=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">BHIVA: Guidelines for antiretroviral treatment of HIV-2-positive individuals</a> (2010)</p><p/><p class=\"headingAnchor\" id=\"H1564762225\"><span class=\"h1\">Australia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://arv.ashm.org.au/&amp;token=seiADJhrCFwpoZFbFFjYdwrPvAroeS1AUq2RvWLCwTM=&amp;TOPIC_ID=111624\" target=\"_blank\" class=\"external\">Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM): Antiretroviral guidelines</a></p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 111624 Version 2.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1187718400\" id=\"outline-link-H1187718400\">Introduction</a></li><li><a href=\"#H612570590\" id=\"outline-link-H612570590\">International</a></li><li><a href=\"#H382525013\" id=\"outline-link-H382525013\">Canada</a></li><li><a href=\"#H3064355763\" id=\"outline-link-H3064355763\">United States</a></li><li><a href=\"#H1634977207\" id=\"outline-link-H1634977207\">Europe</a></li><li><a href=\"#H748854177\" id=\"outline-link-H748854177\">United Kingdom</a></li><li><a href=\"#H1564762225\" id=\"outline-link-H1564762225\">Australia</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-opportunistic-infections-in-hiv-infected-adults-and-adolescents\" class=\"medical medical_society_guidelines\">Society guideline links: Opportunistic infections in HIV-infected adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-sexually-transmitted-infections\" class=\"medical medical_society_guidelines\">Society guideline links: Sexually transmitted infections</a></li></ul></div></div>","javascript":null}